Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal

Federal regulations

Agency
  • DOC231
  • DOT212
  • SEC201
  • HHS185
  • FDA159
  • DOE146
  • DHS142
  • FERC130
  • FAA96
  • EPA83
  • NOAA76
  • NIH53
  • DOJ51
  • Treasury50
  • USDA47
  • DOL38
  • FCC25
  • SBA23
  • CMS18
  • IRS18
  • HUD17
  • FTC5
  • Topic
    • Legal3
    • Marketing3
    • Advertising1
    • Compliance1
    • Product Development1
    • Sales1
    Recency
    • Last 30 days
    • Last 7 days
    CMSRemove filter: CMSFTCRemove filter: FTCNIHRemove filter: NIHClear all
    • Center for Scientific Review; Notice of Closed Meetings
      June 17, 2026

      Center for Scientific Review will hold closed meetings to review research grant applications and provide advice on scientific matters to the National Institutes of Health.

    • Center for Scientific Review; Amended Notice of Meeting
      June 17, 2026

      Center for Scientific Review amended notice of meeting for the National Institutes of Health scientific review group; meeting details and date available in Federal Register notice.

    • Government Owned Inventions Available for License: Establishment and Characterization of the A1847 Human Ovarian Carcinoma Line
      June 16, 2026

      The National Cancer Institute offers licensing of the A1847 human ovarian carcinoma cell line, a BRCA1-deficient model for researchers studying cell cycle regulation, tumor suppression, and DNA damage repair drugs.

    • Center for Scientific Review; Notice of Closed Meetings
      June 16, 2026

      Center for Scientific Review will hold closed meetings to review grant applications and personnel matters; specific dates and locations available upon request to the designated agency contact.

    • Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
      June 16, 2026

      Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.

    • Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
      June 16, 2026

      NIH submits its Extramural Harassment Web Form for OMB review under the Paperwork Reduction Act, with a 30-day public comment period.

    • Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
      June 16, 2026

      Proposed rule codifies Medicare Drug Price Negotiation Program under the Inflation Reduction Act of 2022 and establishes new policies for drug benefit programs and fixed combination drugs.

    • Agency Information Collection Activities: Submission for OMB Review; Comment Request
      June 16, 2026

      CMS is soliciting public comments on proposed information collection activities under the Paperwork Reduction Act; interested parties may submit feedback on burden estimates and collection methodology.

    • Center for Scientific Review; Amended Notice of Meeting
      June 15, 2026

      Center for Scientific Review announces amended open meeting schedule to discuss peer review processes and grant evaluation procedures for National Institutes of Health funding cycles.

    • Government Owned Inventions Available for License: Fluorophthalimides as Anti-Inflammatory Agents for Systemic and Neurodegenerative Disorders
      June 15, 2026

      National Institute on Aging offers licensing opportunities for fluorophthalimide compounds in development as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.

    Page 1 of 8 (76 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Alabama
    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Kentucky
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants